Martina Rozumberkova is a Principal within Control Risks’ Compliance, Forensics and Intelligence practice in the Americas. She has over 17 years of experience assisting companies with fraud and forensic investigations as well as reviews, assessments, development and implementation of global compliance programs, and internal controls. She advises companies conducting investigations involving the FCPA and helps address regulatory actions with focused expertise assisting the life science industry. She has also led teams conducting regulatory mandated monitorships.
In 2019, Martina was part of a team recognized as Compliance Consulting Team of the Year at the C5 Women in Compliance Awards. She co-authored two articles for Global Investigation Review: Guide to Monitorships in 2024 and 2026. In 2026, Martina was named Vice-Chair of the Boston chapter of Women in Bio (WIB).
Martina recently wrote an article for the Global Investigation Review's Guide to Monitorships; Financial services industry monitorships and their impact on cryptocurrency.
Recent tasks that Martina has worked on include:
Prior to joining Control Risks, she led the Commercial Monitoring team at Sanofi Genzyme, where she developed and supervised internal testing programs and methodologies, assessed gaps, prepared remediation plans to enhance internal controls to comply with US laws and regulations, and conducted internal investigations. She also oversaw Sanofi Genzyme’s efforts to comply with its Corporate Integrity Agreement with the Inspector General’s Office of the US Department of Health and Human Services.
Martina is a Certified Anti-Money Laundering Specialist and a Certified Fraud Examiner. She speaks Spanish, Czech, Russian and French.